News Related to Colistin

Related coverage linked through entity extraction aliases.

FDA Approves BioVersys Phase 3 Trial for Drug-Resistant Pneumonia Treatment

Mar 16, 2026

BioVersys AG received FDA approval to enroll U.S. patients in a global Phase 3 trial evaluating BV100 for hospital-acquired pneumonia caused by carbapenem-resistant Acinetobacter baumannii, with trial completion expected by end of 2027.

Extensively Drug-Resistant Salmonella Outbreak Linked to Rosabella Moringa Capsules

Feb 13, 2026

CDC and FDA are investigating a multistate outbreak of extensively drug-resistant Salmonella Newport infections linked to Rosabella brand moringa powder capsules, with seven people sickened across seven states and three requiring hospitalization.